Answers are grounded in this paper and cite their sources.
A novel therapy demonstrates effectiveness in resolving intertrigo, highlighting new treatment possibilities for skin inflammation.
Cold atmospheric plasma (CAP) with ViroCAP‐plasma represents a promising therapeutic innovation in dermatology, offering clinicians a nonpharmacologic option for managing inflammatory skin conditions like intertriginous dermatitis, especially when conventional treatments are contraindicated, ineffective, or poorly tolerated.
No takes yet. Share an insight, caveat, or question.
Vinas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: